As of 2025-07-04, the Intrinsic Value of Biocube Inc (BICB) is -0.05 USD. This BICB valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Biocube Inc is -23,724.15%.
Based on its market price of 0.00 USD and our intrinsic valuation, Biocube Inc (BICB) is overvalued by 23,724.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.05 - -0.05 | -0.05 | -23,724.15% |
| DDM - Stable | (0.07) - (1.82) | (0.95) | -472827.4% |
| DDM - Multi | (0.05) - (1.16) | (0.10) | -50163.3% |
| Market Cap (mil) | 0.02 |
| Beta | -0.74 |
| Outstanding shares (mil) | 96.74 |
| Enterprise Value (mil) | 1.05 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.15% |
| Cost of Debt | 5.00% |
| WACC | 3.79% |